These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10672594)

  • 41. Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease.
    Xia W; Zhang J; Perez R; Koo EH; Selkoe DJ
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8208-13. PubMed ID: 9223340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Presenilin mutations in familial Alzheimer disease and transgenic mouse models accelerate neuronal lysosomal pathology.
    Cataldo AM; Peterhoff CM; Schmidt SD; Terio NB; Duff K; Beard M; Mathews PM; Nixon RA
    J Neuropathol Exp Neurol; 2004 Aug; 63(8):821-30. PubMed ID: 15330337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease.
    Alves da Costa C; Sunyach C; Pardossi-Piquard R; Sévalle J; Vincent B; Boyer N; Kawarai T; Girardot N; St George-Hyslop P; Checler F
    J Neurosci; 2006 Jun; 26(23):6377-85. PubMed ID: 16763046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.
    Borchelt DR; Ratovitski T; van Lare J; Lee MK; Gonzales V; Jenkins NA; Copeland NG; Price DL; Sisodia SS
    Neuron; 1997 Oct; 19(4):939-45. PubMed ID: 9354339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.
    Bentahir M; Nyabi O; Verhamme J; Tolia A; Horré K; Wiltfang J; Esselmann H; De Strooper B
    J Neurochem; 2006 Feb; 96(3):732-42. PubMed ID: 16405513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology.
    Lemere CA; Lopera F; Kosik KS; Lendon CL; Ossa J; Saido TC; Yamaguchi H; Ruiz A; Martinez A; Madrigal L; Hincapie L; Arango JC; Anthony DC; Koo EH; Goate AM; Selkoe DJ; Arango JC
    Nat Med; 1996 Oct; 2(10):1146-50. PubMed ID: 8837617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein.
    Citron M; Eckman CB; Diehl TS; Corcoran C; Ostaszewski BL; Xia W; Levesque G; St George Hyslop P; Younkin SG; Selkoe DJ
    Neurobiol Dis; 1998 Aug; 5(2):107-16. PubMed ID: 9746908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel mutations and repeated findings of mutations in familial Alzheimer disease.
    Finckh U; Kuschel C; Anagnostouli M; Patsouris E; Pantes GV; Gatzonis S; Kapaki E; Davaki P; Lamszus K; Stavrou D; Gal A
    Neurogenetics; 2005 May; 6(2):85-9. PubMed ID: 15776278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attenuated presenilin-1 endoproteolysis enhances store-operated calcium currents in neuronal cells.
    Ryazantseva M; Skobeleva K; Glushankova L; Kaznacheyeva E
    J Neurochem; 2016 Mar; 136(5):1085-95. PubMed ID: 26678016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Gene diagnosis of Alzheimer's disease and Parkinson's disease].
    Tanaka S
    Rinsho Byori; 2002 Oct; 50(10):965-9. PubMed ID: 12451676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The nonconserved hydrophilic loop domain of presenilin (PS) is not required for PS endoproteolysis or enhanced abeta 42 production mediated by familial early onset Alzheimer's disease-linked PS variants.
    Saura CA; Tomita T; Soriano S; Takahashi M; Leem JY; Honda T; Koo EH; Iwatsubo T; Thinakaran G
    J Biol Chem; 2000 Jun; 275(22):17136-42. PubMed ID: 10748144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue.
    Podlisny MB; Citron M; Amarante P; Sherrington R; Xia W; Zhang J; Diehl T; Levesque G; Fraser P; Haass C; Koo EH; Seubert P; St George-Hyslop P; Teplow DB; Selkoe DJ
    Neurobiol Dis; 1997; 3(4):325-37. PubMed ID: 9173929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.
    Borchelt DR; Thinakaran G; Eckman CB; Lee MK; Davenport F; Ratovitsky T; Prada CM; Kim G; Seekins S; Yager D; Slunt HH; Wang R; Seeger M; Levey AI; Gandy SE; Copeland NG; Jenkins NA; Price DL; Younkin SG; Sisodia SS
    Neuron; 1996 Nov; 17(5):1005-13. PubMed ID: 8938131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intracellular Calcium Dysregulation by the Alzheimer's Disease-Linked Protein Presenilin 2.
    Galla L; Redolfi N; Pozzan T; Pizzo P; Greotti E
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1.
    Li YM; Xu M; Lai MT; Huang Q; Castro JL; DiMuzio-Mower J; Harrison T; Lellis C; Nadin A; Neduvelil JG; Register RB; Sardana MK; Shearman MS; Smith AL; Shi XP; Yin KC; Shafer JA; Gardell SJ
    Nature; 2000 Jun; 405(6787):689-94. PubMed ID: 10864326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and beta-amyloid precursor protein.
    Weidemann A; Paliga K; Dürrwang U; Czech C; Evin G; Masters CL; Beyreuther K
    Nat Med; 1997 Mar; 3(3):328-32. PubMed ID: 9055862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
    Gómez-Isla T; Growdon WB; McNamara MJ; Nochlin D; Bird TD; Arango JC; Lopera F; Kosik KS; Lantos PL; Cairns NJ; Hyman BT
    Brain; 1999 Sep; 122 ( Pt 9)():1709-19. PubMed ID: 10468510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thapsigargin affects presenilin-2 but not presenilin-1 regulation in SK-N-BE cells.
    Rivabene R; Visentin S; Piscopo P; De Nuccio C; Crestini A; Svetoni F; Rosa P; Confaloni A
    Exp Biol Med (Maywood); 2014 Feb; 239(2):213-24. PubMed ID: 24363250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel presenilin mutations within Moroccan patients with Early-Onset Alzheimer's Disease.
    El Kadmiri N; Zaid N; Zaid Y; Tadevosyan A; Hachem A; Dubé MP; Hamzi K; El Moutawakil B; Slassi I; Nadifi S
    Neuroscience; 2014 Jun; 269():215-22. PubMed ID: 24704512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcium Signaling and Mitochondrial Function in Presenilin 2 Knock-Out Mice: Looking for Any Loss-of-Function Phenotype Related to Alzheimer's Disease.
    Rossi A; Galla L; Gomiero C; Zentilin L; Giacca M; Giorgio V; Calì T; Pozzan T; Greotti E; Pizzo P
    Cells; 2021 Jan; 10(2):. PubMed ID: 33494218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.